The Trump administration plans to pump millions of dollars into producing more medications in the U.S. as the coronavirus pandemic heightens longstanding concerns about the fragility of the global drug supply chain. On Tuesday, the Biomedical Advanced Research and Development Authority awarded a $345 million contract to a group led by Virginia-based drug company Phlow Corp. to…

A few weeks ago an evocative meme was making the social media rounds: a picture of the leaders of Germany, New Zealand, Belgium, Finland, Iceland and Denmark with the caption “COVID-19 is everywhere but countries with heads of state managing the crisis better seem to have something in common…” Of course the answer was that they were…

(Reuters) – The U.S. Centers for Disease Control and Prevention (CDC) plans a nationwide study of up to 325,000 people to track how the new coronavirus is spreading across the country into next year and beyond, a CDC spokeswoman and researchers conducting the effort told Reuters. The CDC study, expected to launch in June or…

Gilead Sciences, the drug company behind the experimental Covid-19 therapy remdesivir, has upped the number of doses it’s donating to the federal government from 607,000 to around 940,000, STAT has learned. The new number appeared, with no acknowledgement of the shift, in a letter that a U.S. Department of Health and Human Services official sent to…

Beer and soft drinks could soon be sipped from “all-plant” bottles under new plans to turn sustainably grown crops into plastic in partnership with major beverage makers. A biochemicals company in the Netherlands hopes to kickstart investment in a pioneering project that hopes to make plastics from plant sugars rather than fossil fuels. The plans,…

The Bioeconomy Research And Development Act Of 2020 Would Strengthen And Broaden Research In Engineering Biology As Scientists And Researchers Search For Vaccine Amidst COVID-19 Emergency Today, U.S. Senators Kirsten Gillibrand (D-NY), Ed Markey (D-MA), Marco Rubio (R-FL), and Cory Gardner (R-CO) introduced bipartisan legislation to strengthen America’s bioeconomy. As scientists and researchers rush to develop a…

The Advanced Medical Technology Association (AdvaMed) has released new compliance guidance for medical-technology companies to guide them in mitigating compliance and corruption risks as they help healthcare providers fight the coronavirus pandemic. Among the topics addressed in the AdvaMed compliance guidance include ongoing contractual/legal obligations during a declared state of emergency; charitable donations that include products, equipment,…

Boehringer Ingelheim is boosting its early-stage bets while also inking a new deal to work on a therapy against a leading cause of blindness. First up is the German pharma’s preclinical deal with Northern Biologics, which sees it grab the biotech’s early work on therapeutic antibodies targeting the tumor microenvironment, an emerging area in cancer immunology…

The US Food and Drug Administration (FDA) on Monday evening issued two guidances intended to accelerate the development of products to treat or prevent coronavirus disease (COVID-19), laying out recommendations to help companies get to the investigational new drug application (IND) stage and clinical trial design considerations for later-stage studies. “Accelerating the investigation of safe and…